Benzene formation when mixed with vitamin C
When benzoate preservatives meet ascorbic acid (vitamin C) in an acidic drink, a chemical reaction can produce benzene. Heat and light speed the reaction up. Benzene is classified by IARC as a Group 1 carcinogen, meaning it causes cancer in humans, with leukaemia the best-established outcome. The FDA tested around 200 beverages in 2006 and found that most contained no detectable benzene or levels below 5 parts per billion; four products exceeded the EPA drinking-water limit and were reformulated. UK FSA testing in 2008 found 99 per cent of 250 soft drinks within legal limits. The real-world risk depends on product formulation and storage, but the formation pathway is established chemistry.
Benzene is a Group 1 human carcinogen, sufficient evidence that it causes acute myeloid leukaemia; successive IARC Monograph evaluations from 1974 through to Volume 120 in 2018 have consistently upheld this classification.
2018EstablishedIARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 120
The FDA found that benzoate salts combined with vitamin C in beverages can produce benzene; testing of around 200 beverages in 2006 found four products exceeded the EPA drinking-water guidance of 5 ppb, all of which were subsequently reformulated.
2006RegulatoryUS FDA, Questions and Answers on Benzene in Soft Drinks
A UK FSA survey of 250 soft drinks in 2008 found that 99 per cent were within legal limits for benzoates; the survey confirmed the risk of benzene formation when both benzoate preservatives and ascorbic acid are present.
2008RegulatoryUK Food Standards Agency, Benzoate and Sorbate Survey
Children's daily intake can exceed the regulatory limit
The EFSA panel that re-evaluated benzoate preservatives in 2016 set a group acceptable daily intake of 5mg per kilogram of body weight per day for the whole benzoate family (E210 to E213). It found that toddlers and children who regularly drink flavoured soft drinks, in what EFSA called a 'brand-loyal' pattern, exceed this intake level. When additional exposure from natural benzoic acid in fruits and vegetables is included, exceedance extended to the broader child population at higher consumption levels.
EFSA set a group ADI of 5mg/kg body weight per day for benzoic acid and its salts (E210-E213) and found that this ADI was exceeded in the brand-loyal scenario for toddlers and children who regularly consume flavoured drinks; when carry-over from processed fruit and vegetables is included, intake could rise two to threefold above the ADI.
2016Regulatory reviewEFSA Scientific Opinion on re-evaluation of benzoic acid (E210), sodium benzoate (E211), potassium benzoate (E212) and calcium benzoate (E213), EFSA Journal 2016;14(3):4433
Possible link to hyperactivity in children
The most cited study on this question is the McCann et al. 2007 Lancet trial from the University of Southampton. It found that mixes of synthetic food colours together with sodium benzoate increased hyperactivity scores in 3-year-old and 8 to 9-year-old children in the general population. EFSA reviewed the study and concluded it provided limited evidence of a small effect on activity and attention in some children, but noted that the results were not consistent across age groups or between the two additive mixtures tested. Critically, because the cocktails always contained both colours and benzoate, the role of the benzoate alone cannot be isolated from this study.
A randomised, double-blinded, placebo-controlled trial found that mixes of artificial food colours and sodium benzoate increased hyperactivity in 3-year-old and 8 to 9-year-old children in the general population.
2007RCTMcCann et al., The Lancet
EFSA's AFC Panel concluded the McCann 2007 study provided limited evidence of a small effect on activity and attention in some children, with results not consistent across age groups or between the two additive mixtures; EFSA could not confirm sodium benzoate as the causative agent given that colours were always present in the same mix.
2008Regulatory reviewEFSA, Scientific Opinion of the AFC Panel, EFSA Journal 2008;660
Adverse reactions in people sensitive to aspirin
Clinical provocation studies have found that a subset of people with aspirin hypersensitivity, asthma, or chronic urticaria also react to benzoate preservatives. Reactions documented include bronchoconstriction, skin rashes, and urticaria. The intolerance appears related to shared pharmacological mechanisms rather than true immune allergy. Prevalence estimates from provocation studies range from around 2 per cent in rhinitis patients to roughly 11 per cent in people with asthma.
Provocation with sulphur dioxide, sodium benzoate and tartrazine in orange drinks caused bronchoconstriction in a subset of asthma patients; benzoate sensitivity was documented as a distinct reaction pattern.
1977ObservationalFreedman, Clinical and Experimental Allergy
Oral provocation tests with aspirin, tartrazine and benzoic acid revealed intolerance to additives in 26.6 per cent of 620 patients tested; benzoate intolerance specifically ranged from 2.5 per cent in rhinitis patients to 11.5 per cent in asthma patients.
1985ObservationalGenton et al., clinical provocation study (various PubMed-indexed sources)